2.2201
Oramed Pharmaceuticals Inc (ORMP) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
100.00%
-
|
2.00 | - | - | - |
Cost Of Revenue |
100.00%
-
|
1.987 | - | - | - |
Gross Profit |
100.00%
-
|
0.013 | - | - | - |
|
44.85%
2.489
|
4.513 | - | - | - |
Benefits Costs and Expenses |
245.00%
-13.13
|
9.058 | - | - | - |
Costs And Expenses |
245.00%
-13.13
|
9.058 | - | - | - |
Operating Income/Loss |
44.69%
-2.489
|
-4.50 | -3.595 | -3.089 | -3.135 |
Nonoperating Income/Loss |
700.70%
15.37
|
-2.558 | -6.188 | -15.42 | 14.23 |
Income/Loss From Continuing Operations Before Tax |
286.09%
13.13
|
-7.058 | -9.783 | -18.51 | 10.84 |
Income Tax Expense/Benefit |
121.58%
-0.126
|
0.584 | 0.416 | 1.133 | 1.634 |
Income/Loss From Continuing Operations After Tax |
273.51%
13.26
|
-7.642 | -10.20 | -19.64 | 9.204 |
|
273.51%
13.26
|
-7.642 | -10.16 | -19.64 | 9.204 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-0.028
|
- | 0.076 | -0.023 | -0.008 |
Basic Average Shares |
1.25%
41.74
|
41.23 | -0.0537 | 40.90 | 40.96 |
Diluted Average Shares |
3.35%
42.61
|
41.23 | -0.0537 | 40.90 | 41.59 |
Basic Earnings Per Share |
268.42%
0.32
|
-0.19 | -0.26 | -0.48 | 0.22 |
Diluted Earnings Per Share |
263.16%
0.31
|
-0.19 | -0.26 | -0.48 | 0.22 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):